Sector News

Alexion Names David Hallal COO

September 18, 2014
Life sciences
(RTTNews) – Alexion Pharmaceuticals, Inc., whose durg Soliris treats two rare diseases, Wednesday said it is promoting David Hallal to the newly created position of chief operating officer.
 
Hallal, who joined the company in 2006, was previously its executive vice president and chief commercial officer. He led the launch of Soliris. Before Alexion, he was worked at Biogen Idec and Amgen.
 
The company also promoted two members of the management to executive vice president from vice president: Chief Human Resources Officer Clair Carmichael ; and General Counsel John Moriarty.
 
The company further said it appointed Edward Miller to the nearly created position of Senior Vice President and Chief Compliance Officer.
 

comments closed

Related News

October 10, 2021

Nutraceutical giants’ partnerships inject life back into industry at Vitafoods

Life sciences

Some of industry’s biggest players are joining forces to bring cost-effective yet scientifically backed offerings to the nutraceuticals market. Co-creation is reinvigorating supplement innovation, pairing together companies’ diverse expertise, sales networks and clinical trial investments.

October 10, 2021

Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa

Life sciences

GlaxoSmithKline has spent many years developing and testing its world-first malaria vaccine, but even after a positive recommendation from European regulators in 2015, the shot still isn’t widely deployed. That’s set to change with the World Health Organization’s (WHO’s) blessing for the vaccine.

October 10, 2021

Henrietta Lacks’ estate sues Thermo Fisher for continued sale of HeLa cells without family consent

Life sciences

A sample of Henrietta Lacks’ tissue was taken from her cervix without her consent while she was undergoing cancer treatment at Johns Hopkins Hospital in 1951. Her cells have subsequently been used to develop the polio vaccine, HPV vaccines and gene-mapping techniques and continue to be sold for research purposes by Thermo Fisher Scientific.

Send this to a friend